This article provides a comprehensive guide for researchers and drug development professionals on the critical psychometric properties of reproductive health assessment tools.
Endocrine-disrupting chemicals (EDCs) present a significant and ubiquitous public health challenge, yet individual and societal responses are mediated by complex risk perceptions.
This article provides a comprehensive framework for developing, validating, and applying Theory of Planned Behavior (TPB) questionnaires in reproductive health research.
This article provides a comprehensive analysis of endocrine-disrupting chemicals (EDCs) and their multifaceted impact on reproductive health, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of Endocrine-Disrupting Chemical (EDC) exposure routes—food, air, and skin absorption—and their implications for human health and drug development.
This article provides a comprehensive analysis of the comparative effectiveness of available osteoporosis medications in reducing fracture risk, tailored for researchers, scientists, and drug development professionals.
This article synthesizes current evidence on the long-term cognitive effects of menopausal hormone therapy (MHT), addressing a critical area of concern and opportunity in women's brain health.
This article addresses the critical global challenge of undertreatment in post-fracture osteoporosis, a condition affecting over 500 million people worldwide.
This article synthesizes current evidence on the age-dependent outcomes of vitamin D supplementation, a critical area for research and drug development.
This article provides a critical comparison for researchers and drug developers between Growth Hormone Secretagogues (GHSs) and recombinant human Growth Hormone (rhGH).